The Effect of E-Booklet Traınıng on Self-Effıcacy and Comfort Level in Patıents Wıth Urınary Catheter

NCT ID: NCT06829927

Last Updated: 2025-02-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-09-15

Study Completion Date

2025-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Urinary catheterization is the insertion of a tube through the urethra into the bladder to empty or flush the bladder. Catheterization is preferred in patients with urinary retention and urinary incontinence, in patients who will undergo surgical intervention or in cases where a procedure needs to be performed in the urinary tract, and is applied for short (1-7 days), medium (7-28 days) and long term (longer than 28 days) (National Institute of Diabetes and Digestive and Kidney Diseases. (2023). Urinary catheterization is frequently preferred in applications related to treatment and care. According to the CAUTI report, the frequency of urinary catheterization in hospitalized patients in one year is between 15-25% in the world. This rate is between 10-15% in developed countries and 20-30% in developing countries (CAUTI, 2015).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Urinary catheterization is generally preferred for short-term care and treatment (Clarke et al., 2020; Cutinho et al., 2018). Urinary catheterization is critical in routine health care and can cause many complications such as urinary tract infection, epididymitis, catheter obstruction, trauma, pain, bladder spasm, and hematuria if not used appropriately.Darbyshire et al. (2016) found that 32% of patients experienced leakage, 26% experienced pain, 26% experienced discomfort and 24% experienced obstruction.In fact, it is estimated that 450,000 people in the UK undergo short-term urinary catheterization and complications related to urinary catheter use cause 2100 deaths annually (Feneley et al., 2015).

Although urinary tract infection due to catheterization is common, patients' failure to perform appropriate behaviors and practices related to catheterization causes the infection to progress and the treatment process to be prolonged.Urinary tract infections account for approximately 20% of healthcare-acquired infections in acute care facilities and more than 50% in long-term care facilities (Zegeye et al., 2023). In the United States, urinary tract infections account for 32% of all hospital-acquired infections and are the most common type of hospital-acquired infection, with approximately 449,000 cases of urinary tract infections and an estimated cost of $450 million per year (Abiodun, 2018). In cases where they are not inserted under appropriate conditions, care is not provided effectively and treatment protocols are not followed, they pave the way for the development of resistant microorganisms. Accordingly, urinary tract infection, which requires a long treatment process in patients, causes many negative consequences, including prolonged hospital stay, increased in-hospital mortality and increased health care costs (Anderson et al., 2021; Cutinho et al., 2018; Snyder et al., 2023).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Urinary Catheter

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

This study was planned as a Randomized Controlled Trial to determine urinary catheter-related self-efficacy and comfort levels of patients hospitalized in a university hospital.
Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors
Double blind method will be used in the study. Participants will not know which group they are assigned to and statistics will be performed by an independent person to minimize the risk of bias

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control Group

Patients in the control group will not be given any content and their routine care and education will continue. Patients in the control group will be asked to complete the Urinary Catheter Self-Efficacy Scale and Comfort Scale at the 6th and 24 th hours following urinary catheter insertion.

Group Type NO_INTERVENTION

No interventions assigned to this group

intervention group

Patients in the intervention group will be informed about the urinary catheter by the researcher after catheter insertion, and the link to the e-booklet will be given and the patients will be asked to review it. Patients will be asked to fill out the Urinary Catheter Self-Efficacy Scale and Comfort Scale at the 6th and 24th hour following urinary catheter insertion. After the completion of the study, the link to the e-booklet will be given to the patients in the control group to maintain the principle of equality. The research data will be collected by the researcher between 30.09.2024 and 30.10.2025 via Google survey.

Group Type ACTIVE_COMPARATOR

e-book

Intervention Type BEHAVIORAL

Patients with pilot application will not be included in the study. Patients who agree to participate in the study will be informed by the researcher about the purpose and process of the study, and their written and verbal informed consent will be obtained. Patients will be informed that the decision on whether or not to participate in the study is entirely their own, that no money will be deducted from their health insurance or any money will be paid to them, that the data to be collected from this study will only be used within the scope of the research, and that confidentiality will be strictly ensured. Pretests (Personal Information Form, Urinary Catheter Self-Efficacy Scale and Comfort Scale) will be administered to the patients whose consent is obtained.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

e-book

Patients with pilot application will not be included in the study. Patients who agree to participate in the study will be informed by the researcher about the purpose and process of the study, and their written and verbal informed consent will be obtained. Patients will be informed that the decision on whether or not to participate in the study is entirely their own, that no money will be deducted from their health insurance or any money will be paid to them, that the data to be collected from this study will only be used within the scope of the research, and that confidentiality will be strictly ensured. Pretests (Personal Information Form, Urinary Catheter Self-Efficacy Scale and Comfort Scale) will be administered to the patients whose consent is obtained.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Patients who can actively use information technologies such as phones and tablets

* Inpatients in the Urology Clinic
* Conscious and oriented patients
* Patients aged 18-75 years
* Patients with short-term catheterization
* Patients without hearing and communication disabilities
* Literate patients

Exclusion Criteria

* Patients who incompletely completed the data collection tool
* Patients with hearing, vision and comprehension problems,
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

TOGÜ

UNKNOWN

Sponsor Role collaborator

Cumhuriyet University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Şeyda KAZANÇ

Öğr. Gör. Dr.

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Hülya Koçyiğit KAVAK

Role: STUDY_CHAIR

Cumhuriyet University

Şerife Karagözoğlu, Prof. Dr.

Role: PRINCIPAL_INVESTIGATOR

Cumhuriyet University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Tokat Gaziosmanpaşa University

Tokat/Merkez, Tokat Province, Turkey (Türkiye)

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Şeyda KAZANÇ, Asst. Prof.

Role: CONTACT

05377782297

Hülya Koçyiğit KAVAK, Asst. Dr.

Role: CONTACT

05377782297

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Şeyda

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Hülya KOÇYİĞİT KAVAK

Identifier Type: OTHER

Identifier Source: secondary_id

TOGÜ

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Discharge Education in Diabetic Surgical Patients
NCT06777836 NOT_YET_RECRUITING NA